Blinatumomab Gets 100% Response Rate Before MTD

Aug. 20, 2008

By Anette Breindl

Current Heparin Production Method Called Vulnerable

Aug. 19, 2008

By Anette Breindl

Blinatumomab Gets 100% Response Rate Before MTD

Aug. 15, 2008

By Anette Breindl

Immune Suppressant Can Stimulate Immune System

Aug. 14, 2008

By Anette Breindl

RNAi Broadens its Horizons, Takes Aim at HIV, Cholesterol

Aug. 12, 2008

By Anette Breindl

Sense-Antisense Pair Feeds Each Other, Amyloid Plaques

Aug. 11, 2008

By Anette Breindl

NewCo News: Sea Lane Biotechnologies Describes New 'Surrobodies'

Aug. 7, 2008

By Anette Breindl

Postpartum Depression Tied to Lack of Receptor Subunit

Aug. 5, 2008

By Anette Breindl

iPS Cells from ALS Patients May Help Research, Therapy

Aug. 1, 2008

By Anette Breindl

Slowly, Schizophrenia Begins to Yield its Genomic Secrets

July 31, 2008

By Anette Breindl